| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/07/2004 | EP1232249B1 Duck pneumovirus and corresponding vaccines |
| 07/07/2004 | EP0928198B1 Vaccine composition comprising outer membrane protein fragments of bordetella pertussis |
| 07/07/2004 | CN1511164A Peptides presented by cells |
| 07/07/2004 | CN1511041A Methods of treating antibody-mediated pathologies using agents which inhibit CD 21 |
| 07/07/2004 | CN1511040A Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 07/07/2004 | CN1511033A Liquid drug preparations |
| 07/07/2004 | CN1511017A Treating epidermlyosis bullosa with thymosin Beta-4 |
| 07/07/2004 | CN1510147A Determination of alpha-N-acetamino galactosidase activity |
| 07/07/2004 | CN1510137A Gene identification |
| 07/07/2004 | CN1510130A Attenuated cattle viral diarrhoea virus |
| 07/07/2004 | CN1510129A Structure for recombinant adenovirus with double killer function and application in tumor treatment |
| 07/07/2004 | CN1510052A Tumour necrosis factor antibody preparing method and medicinal composition thereof |
| 07/07/2004 | CN1509765A Freezed dry preparation of lecithal antibody and its producing method |
| 07/07/2004 | CN1509764A Preparation of target gene virus medicine against cancers |
| 07/07/2004 | CN1156491C Modified treponema pallidum outer membrane protein, its immunoassay use and immunoassay kit |
| 07/06/2004 | US6759518 Single-chain multiple antigen-binding molecule, its preparation and use |
| 07/06/2004 | US6759517 Allergenic proteins of natural rubber latex, their production and use in assays |
| 07/06/2004 | US6759516 Methods of identifying antigen gene sequences |
| 07/06/2004 | US6759515 A prostate-specific protein, and to polynucleotides encoding such polypeptides |
| 07/06/2004 | US6759508 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/06/2004 | US6759241 Isolated from gram negative bacterial strains that contain at least one mutation in at least one of the htrb and msbb genes, used as a vaccine |
| 07/06/2004 | US6759239 Reduction of risk of rejection of allografts and xenografts and autoimmune diseases using the human suppressor cd8+cd28- t cells |
| 07/06/2004 | US6759234 Used to treat protein allergen sensitivity in humans |
| 07/06/2004 | US6759213 Haemophilus adhesion proteins |
| 07/06/2004 | US6759210 Compositions and methods for the treatment and diagnosis of cardiovascular disease using fehd545 as a target |
| 07/06/2004 | US6759201 Method of identifying a neural progenitor cell by evaluating expression of daedalos |
| 07/06/2004 | US6759194 Nucleotide sequences encoding peroxisome-associated polypeptides, and their uses in the diagnosis and/or treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 07/06/2004 | US6759189 Early detection of lysosomal storage disorders |
| 07/06/2004 | US6759048 Neutralization-sensitive epitopes of Cryptosporidium parvum |
| 07/06/2004 | US6759046 Peptides |
| 07/06/2004 | US6759045 Administering antibodies; anticancer agents |
| 07/06/2004 | US6759044 Cryptopain antibodies for prophylaxis, treatment, diagnosis and detection of Cryptosporidium species |
| 07/06/2004 | US6759043 Monoclonal antibodies having property of causing apoptosis |
| 07/06/2004 | US6759036 Fibrocyte-base vaccine formulations |
| 07/06/2004 | US6759035 Method to prevent graft rejection using TGF-beta to induce T suppressor cells |
| 07/01/2004 | WO2004055517A2 Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 07/01/2004 | WO2004055190A2 Immunization of fish with plant-expressed recombinant proteins |
| 07/01/2004 | WO2004055187A1 Recombinant viral-based malaria vaccines |
| 07/01/2004 | WO2004055183A2 Carcinoembryonic antigen-specific immunodominant epitope recognized by cd4+t cells and uses thereof |
| 07/01/2004 | WO2004055164A2 System and method for stabilizing antibodies with histidine |
| 07/01/2004 | WO2004055161A2 Large scale production of packaged alphavirus replicons |
| 07/01/2004 | WO2004055053A1 Tumor vaccine |
| 07/01/2004 | WO2004055045A1 Salmonella antigen formulation and antibody test kit and subunit vaccine using the same |
| 07/01/2004 | WO2004055043A1 Epitopic peptides of the thyroperoxidase enzyme, compositions containing same and uses thereof |
| 07/01/2004 | WO2004054618A1 Drugs for inhibiting rejection reaction in tissue transplanted into mammalian tissue and method of treating diabetes using the same |
| 07/01/2004 | WO2004054612A1 Subunit vaccine against avian typhoid based on proteins of the outer membrane of salmonella gallinarum |
| 07/01/2004 | WO2004054611A1 Meningococcal vaccine based on outer membrane proteins porb2 and pora |
| 07/01/2004 | WO2004054610A1 Vaccine for fish cold-water disease |
| 07/01/2004 | WO2004054516A2 Antagonists for human prolactin |
| 07/01/2004 | WO2004054508A2 Immunogenic compositions including rough phenotype brucella host strains and complementation dna fragments |
| 07/01/2004 | WO2004044591A3 Use of nuclear hormone receptors to identify meiosis regulating compounds |
| 07/01/2004 | WO2004032870A3 Methods for treating post-surgical pain by admisnistering a nerve growth factor antagonist and compositions containing the same |
| 07/01/2004 | WO2004026240A3 Animal immunocontraceptives expressed in plants and uses thereof |
| 07/01/2004 | WO2004020014A3 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 07/01/2004 | WO2004016801A3 Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs |
| 07/01/2004 | WO2004013151A3 Campylobacter glycans and glycopeptides |
| 07/01/2004 | WO2004007747A3 Assays for assembly of ebola virus nucleocapsids |
| 07/01/2004 | WO2004007540A8 Klebsiella membrane extracts exhibiting advantageous properties, and method for producing said extracts |
| 07/01/2004 | WO2004003511A3 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 07/01/2004 | WO2004001007A3 Buffered formulations for concentrating antibodies and methods of use thereof |
| 07/01/2004 | WO2003106622A3 Methods for treatment of acute lymphocytic leukemia |
| 07/01/2004 | WO2003100435A3 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2) |
| 07/01/2004 | WO2003098212A3 Method of isolating an endotehelial cell and method of donor specific crossmatching |
| 07/01/2004 | WO2003097814A3 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins |
| 07/01/2004 | WO2003092716A3 Therapeutic use of pacap, maxadilan, pacap receptor agonist and/or adcyap1r1 in the treatment of cns disorders |
| 07/01/2004 | WO2003092582A3 Chimeric ebola virus envelopes and uses therefor |
| 07/01/2004 | WO2003087757A3 Particle-bound human immunodeficiency virus envelope clycoproteins and related compositions and methods |
| 07/01/2004 | WO2003080569A3 Egfr ligands and methods of use |
| 07/01/2004 | WO2003078600A3 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 07/01/2004 | WO2003068942A3 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 07/01/2004 | WO2003057822A9 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 07/01/2004 | WO2003042240A3 Polypeptides of pseudomonas aeruginosa |
| 07/01/2004 | WO2003003986A3 Parathyroid hormone antibodies and related methods |
| 07/01/2004 | WO2002099083A3 Gfats as modifiers of the p53 pathway and methods of use |
| 07/01/2004 | WO2002062834A3 Mixture of peptides originating from a nef protein and applications thereof |
| 07/01/2004 | WO2002015846A3 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 07/01/2004 | US20040127696 Growth differentiation factor-7 |
| 07/01/2004 | US20040127689 activated haptens useful for generating immunogens to HIV protease inhibitors |
| 07/01/2004 | US20040127684 Heat shock protein-based vaccines and immunotherapies |
| 07/01/2004 | US20040127455 Muscosal immunoregulatory agent and its use |
| 07/01/2004 | US20040127438 polypeptide (or its encoding nucleic acid molecule from Mycobacterium tuberculosis or related prokaryotes in the treatment of cancer, allergic disorders or conditions of immunoactivation, particularly asthma |
| 07/01/2004 | US20040127408 based on the complementarity-determining region (CDR) of a human monoclonal anti-DNA antibody |
| 07/01/2004 | US20040127401 CA125 gene and its use for diagnostic and therapeutic interventions |
| 07/01/2004 | US20040127400 for inducing antibody production against Streptococcal antigens |
| 07/01/2004 | US20040126880 Using gamma radiation to inactivate, decrease and/or remove contaminants associated with functioning biological materials, biochemical entities and biologically active molecules and storing materials at room temperature |
| 07/01/2004 | US20040126871 Nucleic acid vaccines against rickettsial diseases and methods of use |
| 07/01/2004 | US20040126870 Ncc2705-the genome of a bifodobacterium |
| 07/01/2004 | US20040126862 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 07/01/2004 | US20040126841 Novel G-protein coupled receptor, HLTEX11 |
| 07/01/2004 | US20040126816 Using blood coagulation factor to identify antibodies which modulate, prevent and treat tumors, inflammation, septic shock, hypotension and adult respiratory distress syndrome |
| 07/01/2004 | US20040126808 Small cell lung cancer associated antigens and uses therefor |
| 07/01/2004 | US20040126807 Isolated nucleic acids; polypeptides showing higher expression on cancer cells |
| 07/01/2004 | US20040126799 First nucleotide sequence comprises adenine residue at position 1033 or equivalent; reducing disease treatment side effects |
| 07/01/2004 | US20040126793 Lectin compositions and methods for modulating an immune response to an antigen |
| 07/01/2004 | US20040126754 reacting with the majority of anti-HCV antibodies present in patient sera; bioassays; solid phase synthesis; kits |
| 07/01/2004 | US20040126421 formed from peptide having ubiquitinatable region and antigenic region (with leukemia-/sarcoma- associated oncofusion protein breakpoint region), pH-sensitive liposomal carrier and bilayer-associated adjuvant; vaccines |
| 07/01/2004 | US20040126397 Neuromuscular disorders |
| 07/01/2004 | US20040126396 Pain therapy; administering neurotoxins |
| 07/01/2004 | US20040126395 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 07/01/2004 | US20040126394 Novel composition |